Pharmacist newsletters4/16/2023 ![]() ![]() In this September issue, you'll find articles on ACT EU’s Workplan 2022-2026, Real-world evidence for regulatory decision-making, EFPIA’s Annual Report on the Pharmaceutical industry 2022, and Patient involvement in the development, regulation and safe use of medicines. In this October issue, you'll find articles on Drug substance supply in new product introduction processes, MDCG, a position paper on the capacity of notified bodies, the current status of trade agreements, and a warning from the FDA about manufacturing on the same equipment. In this February issue, you'll find news about The Windsor Framework, a Review of the pharmaceutical legislation, the proposals of the industrial associations, an EMA/EFSA joint report on human dietary exposure to residues of veterinary medicines, pesticides and feed additives, and HERA reports on stockpiling of antimicrobials. Links to assist pharmacists with handling the Opioid Overdose Crisis in New Hampshire.Read the official newsletter of the European Industrial Pharmacists' Group. Opioid Overdose Information for Pharmacists.As there has been some misunderstanding of the terminology used in the Board's laws and rules, the Board would like to remind everyone that whenever the word "shall" is used in its laws/rules that this means it is a mandated requirement, and licensees found in violation are subject to disciplinary sanctions by the Board. JanuNotice Regarding New Shingrix VaccineĪs noted in the Board's October 2016 Newsletter, pharmacists and pharmacies need to be aware that Ph 704.01 of the Board's rules now requires that pharmacists working greater than an 8-hour shift take a 30-minute rest break – it is not optional.FebruNotice on Controlled Drug Loss Reporting.FebruNotice on Sale of Syringes (NH RSA 318:52-c).ApNotice on Use of Third Parties to Submit Online Renewals on Behalf of Licensee.ApNotice on Controlled Substance Electronic Prescriptions.Notice on Pharmacist Obligations to Patient When Refusing to Fill a Prescription.AugNotice on Administration of Vaccines by Pharmacists and Pharmacy Interns.Prescriber's Guide to the New 2019 Medicare Part D Opioid Overutilization Policies.The Centers for Medicare & Medicaid Services (CMS) has provided the following information for both prescribers and pharmacies on its new Medicare Part D Opioid Overutilization Policies for 2019:.Free Addiction / Recovery Services for Board Licensees through NHPHP.Information on Hepatitis A Outbreak in NH from NH DHHS.ApBoard Notice Regarding Mandatory Continuous Quality Improvement Programs at All NH Pharmacies.Information provided by the NH Bureau of Drug & Alcohol Services. View map of NH pharmacies which offer over-the-counter sales of Narcan / Naloxone (via a Standing Order).Results of Prescription Drug Monitoring Program - Data Compliance Audit.Board Notice - CQI (Continuous Quality Improvement).The new law prohibits third parties from completing applications/online renewals on behalf of applicants/licensees, as well as transitions the Board to biennial license renewals. ![]()
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |